Name | Irsenontrine |
---|
Description | Irsenontrine (E2027) is an orally active and selective phosphodiesterase 9 (PDE 9) inhibitor. Irsenontrine can be used for the research of neurological diseases[1]. |
---|---|
Related Catalog | |
Target |
PDE 9[1] |
In Vitro | Irsenontrine (E2027) is an orally active and selective phosphodiesterase 9 (PDE 9) inhibitor[1]. |
References |
Molecular Formula | C22H22N4O3 |
---|---|
Molecular Weight | 390.44 |